Romiplostim (Nplate), a Treatment Option for Immune (Idiopathic) Thrombocytopenic Purpura

Romiplostim (Nplate), a Treatment Option for Immune (Idiopathic) Thrombocytopenic Purpura is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID2799136

P2093author name stringNino Marzella
Diana Hubulashvili
P2860cites workTreatment of immune thrombocytopenic purpura in children : current concepts.Q30351606
Immune thrombocytopenic purpuraQ33341737
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialQ33378523
New options after first-line therapy for chronic immune thrombocytopenic purpuraQ33382751
High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpuraQ33386747
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of HematologyQ33496273
P433issue9
P921main subjectromiplostimQ1235195
P304page(s)482-485
P577publication date2009-09-01
P1433published inP & T: journal for formulary managementQ15767306
P1476titleRomiplostim (Nplate), a Treatment Option for Immune (Idiopathic) Thrombocytopenic Purpura
P478volume34

Search more.